The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Churg-Strauss Syndrome Clinical Study and Long-Term Follow-Up of 96 Patients
Abstract
Churg-Strauss syndrome (CSS) is a systemic vasculitis characterized by the presence of asthma, hypereosinophilia, and necrotizing vasculitis with extravascular eosinophil granulomas. In this retrospective study of 96 patients between 1963 and 1995, we analyzed clinical manifestations, identified prognostic factors, and assessed the long-term outcome. CSS was diagnosed when asthma, hypereosinophilia > 1,500/mm3 or > 10%, and clinical manifestations consistent with systemic vasculitis, with or without histologic evidence, were present. Asthma was the most frequently observed manifestation at presentation, with mononeuritis multiplex the second. Other common manifestations were weight loss, fever, myalgia, skin involvement, paranasal sinusitis, arthralgia, pulmonary infiltrate, and gastrointestinal involvement. Mean eosinophilia at presentation was 7.193 +/- 6.706/mm3; ANCA, present in 20 of 42 (47.6%) patients, predominantly gave the perinuclear labeling pattern. All the patients were treated with corticosteroids alone or in combination with cyclophosphamide or plasma exchanges. Clinical remission was obtained in 91.5%; 22 (25.6%) patients relapsed. Twenty-three patients died during follow-up: 11 of these deaths were directly due to vasculitis. The presence of severe gastrointestinal tract or myocardial involvement was significantly associated with a poor clinical outcome. The long-term prognosis of CSS is good and does not differ from that of polyarteritis nodosa, although most patients need low doses of oral corticosteroids for persistent asthma, even many years after clinical recovery from vasculitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845
Masi, A. T., Hunder, G. G., Lie, J. T., Michel, B. A., Bloch, D. A., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330806 · Cited by 2,215
Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.
Churg, J., & Strauss, L. (1951) · PubMed · Cited by 1,696
Falk, R. J., & Jennette, J. C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806233182504 · Cited by 1,424
Systemic Vasculitis with Asthma and Eosinophilia: A Clinical Approach to the Churg-Strauss Syndrome
LANHAM, J. G., ELKON, K. B., PUSEY, C. D., & HUGHES, G. R. (1984) · Medicine · doi:10.1097/00005792-198403000-00001 · Cited by 1,238
The Spectrum of Vasculitis: Clinical, Pathologic, Immunologic, and Therapeutic Considerations
FAUCI, A. S., HAYNES, B. F., & KATZ, P. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-5-660 · Cited by 1,196
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
Luqmani, R. A., BACON, P. A., Moots, R. J., Janssen, B. A., Pall, A. A., Emery, P., Savage, C. O. S., & Adu, D. (1994) · PubMed · Cited by 1,056
Guillevin, L., Lhote, F., Gayraud, M., Cohen, P., Jarrousse, B., Lortholary, O., Thibult, N., & Casassus, P. (1996) · Medicine · doi:10.1097/00005792-199601000-00003 · Cited by 1,000
Self-citationAllergic Granulomatosis and Angiitis (Churg-Strauss Syndrome)
Chumbley, L. C., Harrison, Jr., & DeRemee, R. A. (1977) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)09873-8 · Cited by 410
Lhote, F. ̧., & Guillevin, L. (1995) · PubMed · Cited by 232
Self-citation
Cited by
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
Wechsler, M. E., Akuthota, P., Jayne, D., Khoury, P., Klion, A., Langford, C. A., Merkel, P. A., Moosig, F., Specks, U., Cid, M. C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1702079 · Cited by 1,094
Comarmond, C., Pagnoux, C., Khellaf, M., Cordier, J., Hamidou, M., Viallard, J., Maurier, F., Jouneau, S., Bienvenu, B., Puéchal, X., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37721 · Cited by 937
Self-citationSinico, R. A., Di Toma, L., Maggiore, U., Bottero, P., Radice, A., Tosoni, C., Grasselli, C., Pavone, L., Gregorini, G., Monti, S., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21250 · Cited by 691
Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Sablé-Fourtassou, R., Cohen, P., Mahr, A., Pagnoux, C., Mouthon, L., Jayne, D., Blockmans, D., Cordier, J.-F., Delaval, P., Puechal, X., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-9-200511010-00006 · Cited by 688
Self-citationNoth, I., Strek, M. E., & Leff, A. R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12518-4 · Cited by 527
Metadata
- Authors
- Guillevin, L., Cohen, P., Gayraud, M., Lhote, F., Jarrousse, B., & Casassus, P.
- Venue
- Medicine
- Published
- 1999-01
- Volume
- 78
- Issue
- 1
- Pages
- 26-37
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2038284056
- Cited by
- 1,074
- References
- 17
- FWCI
- 33.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Churg-Strauss Syndrome Clinical Study and Long-Term Follow-Up of 96 Patients. https://app.cochat.ai/papers/10.1097/00005792-199901000-00003
- The paper
- Guillevin, L., Cohen, P., Gayraud, M., Lhote, F., Jarrousse, B., & Casassus, P. (1999). Churg-Strauss Syndrome Clinical Study and Long-Term Follow-Up of 96 Patients. Medicine. https://doi.org/10.1097/00005792-199901000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.